This invention provides a method for preventing or treating Severe AcuteRespiratory Syndrome in a subject comprising administering to the subject aneffective amount of recombinant super-compound interferon or a functionalequivalent thereof. This invention provides a method for inhibiting thecausative agent of Severe Acute Respiratory Syndrome comprising contacting theagent with an effective amount of super-compound interferon or its equivalent.